Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Warts 2Neutropenia 2Infections 2Immunologic Deficiency Syndromes 2Agammaglobulinemia 2Multiple Myeloma 1Leukopenia 1Leukemia, Plasma Cell 1Hematologic Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

carfilzomib 2Melphalan 2plerixafor 1pegylated granulocyte colony-stimulating factor 1ferric pyrophosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Stem Cell Transplantation 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Hyaluronoglucosaminidase 1Fluorodeoxyglucose F18 1Filgrastim 1Dexamethasone 1Calcium Dobesilate 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Plasma Cell × plerixafor × Clear all
NCT07605416 2026-05-26

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
74 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡